Furazolidone is a nitrofuran antibacterial. It is marketed by Roberts Laboratories under the brand name Furoxone and by GlaxoSmithKline as Dependal-M.
|
Contents
- 1 Uses
- 1.1 Protozoan
- 1.2 Bacterial
- 2 Mechanism
- 3 Side effects
- 4 References
|
Uses
It is used to treat diarrhoea and enteritis caused by bacteria or protozoan infections.
It has also been used in aquaculture.1
Protozoan
Furazolidone is also used for giardiasis (due to Giardia lamblia), though it is not a first line treatment.2
Bacterial
Furazolidone is also used to treat traveler's diarrhoea, cholera, and bacteremic salmonellosis.
As a veterinary medicine, furazolidone has been used with some success to treat salmonids for Myxobolus cerebralis infections.
Use in treating Helicobacter pylori infections has been proposed.3
Mechanism
It is believed to work by crosslinking of DNA.4
Side effects
Furazolidone is no longer available in the US. Though an effective antibiotic when all others fail, against extremely drug resistant infections, it has many side effects, and as with other nitrofurans generally, minimum inhibitory concentrations also produce systemic toxicity (tremors, convulsions, peripheral neuritis, gastrointestinal disturbances, depression of spermatogenesis.) Nitrofurans are recognized by FDA as mutagens/carcinogens, and can no longer be used since 1991.5
References
- ^ Meng J, Mangat SS, Grudzinski IP, Law FC (1998). "Evidence of 14C-furazolidone metabolite binding to the hepatic DNA of trout". Drug Metabol Drug Interact 14 (4): 209–19. PMID 10694929.
- ^ Petri WA (February 2005). "Treatment of Giardiasis" (dead link). Curr Treat Options Gastroenterol 8 (1): 13–17. doi:10.1007/s11938-005-0047-3. PMID 15625030. http://www.treatment-options.com/1092-8472/8/13.
- ^ Machado RS, Silva MR, Viriato A (2008). "Furazolidone, tetracycline and omeprazole: a low-cost alternative for Helicobacter pylori eradication in children". Jornal de pediatria 84 (2): 160–5. doi:10.2223/JPED.1772. PMID 18372934.
- ^ "DrugBank: Showing Furazolidone (DB00614)". http://www.drugbank.ca/drugs/DB00614. Retrieved 2008-12-19.
- ^ http://caraga.da.gov.ph/services/banmed-Nitrofurans.htm
|
Gynecological anti-infectives and antiseptics (G01)
|
|
| Antibiotics |
Candicidin • Chloramphenicol • Hachimycin • Oxytetracycline • Carfecillin • Mepartricin • Clindamycin • Pentamycin
|
|
| Arsenic compounds |
Acetarsol
|
|
| Quinoline derivatives |
Diiodohydroxyquinoline • Clioquinol • Chlorquinaldol • Dequalinium • Broxyquinoline • Oxyquinoline
|
|
| Organic acids |
Lactic acid • Acetic acid • Ascorbic acid
|
|
| Sulfonamides |
Sulfatolamide
|
|
| Antifungals |
|
Imidazoles
|
Metronidazole • Clotrimazole • Miconazole • Econazole • Ornidazole • Isoconazole • Tioconazole • Ketoconazole • Fenticonazole • Azanidazole • Propenidazole • Butoconazole • Omoconazole • Oxiconazole • Flutrimazole
|
|
|
Triazoles
|
Terconazole
|
|
|
Polyenes
|
Nystatin • Natamycin • Amphotericin B
|
|
|
Other
|
Ciclopirox • Methylrosaniline
|
|
|
| Other |
Clodantoin • Inosine • Policresulen • Nifuratel • Furazolidone • Povidone-iodine • Protiofate • Lactobacillus fermentum • Copper usnate
|
|
|
|
|
noco/cong/npls, sysi/epon
|
proc/asst, drug (G1/G2B/G3CD)
|
|
|
|
|
Antiparasitics – antiprotozoal agents – Excavata antiparasitics (P01)
|
|
| Discicristata |
|
Trypanosomiasis
|
African trypanosomiasis: ornithine (Eflornithine#) • arsenical (Melarsoprol#) • benzamidine (Pentamidine#) • naphthalenesulfonate (Suramin#)
Chagas disease: nitroimidazole (Benznidazole #) • nitrofuran (Nifurtimox #)
|
|
|
Leishmaniasis
|
macrolide (Amphotericin B#)
Pentavalent antimonials (Meglumine antimoniate#, Sodium stibogluconate)
benzamidine (Pentamidine #) • phosphorylcholine (Miltefosine) • neomycin (Paromomycin)
|
|
|
PAM
|
macrolide (Amphotericin B)
|
|
|
| Trichozoa |
|
Giardiasis
|
nitroimidazole (Metronidazole#, Tinidazole) • benzimidazole (Albendazole)
thiazole (Nitazoxanide) • nitrofuran (Furazolidone)
aminoacridine (Quinacrine)
|
|
|
Trichomoniasis
|
nitroimidazole (Metronidazole#, Tinidazole)
|
|
|
Dientamoebiasis
|
nitroimidazole (Metronidazole, Secnidazole)
oxyquinoline (Iodoquinol) • tetracycline (Doxycycline) • neomycin (Paromomycin)
|
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
|
Antibacterials: nucleic acid inhibitors (J01E, J01M)
|
|
Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis) |
|
DHFR inhibitor
|
2,4-Diaminopyrimidine (Trimethoprim#, Brodimoprim, Tetroxoprim, Iclaprim†)
|
|
|
Sulfonamides
(DHPS inhibitor)
|
|
Short-
acting
|
Sulfaisodimidine • Sulfamethizole • Sulfadimidine • Sulfapyridine • Sulfafurazole • Sulfanilamide (Prontosil) • Sulfathiazole • Sulfathiourea
|
|
|
Intermediate-
acting
|
Sulfamethoxazole • Sulfadiazine# • Sulfamoxole
|
|
|
Long-
acting
|
Sulfadimethoxine • Sulfalene • Sulfametomidine • Sulfametoxydiazine • Sulfamethoxypyridazine • Sulfaperin • Sulfamerazine • Sulfaphenazole • Sulfamazone
|
|
|
|
Other/ungrouped
|
sulfanilamide (Sulfacetamide, Sulfametrole)
|
|
|
Combinations
|
Trimethoprim/sulfamethoxazole#
|
|
|
Topoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication) |
|
1st g.
|
Cinoxacin‡ • Flumequine • Nalidixic acid • Oxolinic acid • Pipemidic acid • Piromidic acid • Rosoxacin
|
|
|
Fluoro-
quinolones
|
|
2nd g.
|
Ciprofloxacin# • Enoxacin‡ • Fleroxacin‡ • Lomefloxacin • Nadifloxacin • Ofloxacin • Norfloxacin • Pefloxacin • Rufloxacin
|
|
|
3rd g.
|
Balofloxacin • Grepafloxacin‡ • Levofloxacin • Pazufloxacin • Sparfloxacin‡ • Temafloxacin‡ • Tosufloxacin
|
|
|
4th g.
|
Besifloxacin • Clinafloxacin† • Garenoxacin • Gemifloxacin • Moxifloxacin • Gatifloxacin‡ • Sitafloxacin • Trovafloxacin‡/Alatrofloxacin‡ • Prulifloxacin
|
|
|
Vet.
|
Danofloxacin • Difloxacin • Enrofloxacin • Ibafloxacin • Marbofloxacin • Orbifloxacin • Pradofloxacin • Sarafloxacin
|
|
|
Related (DG)
|
Aminocoumarins: Novobiocin
|
|
|
|
Anaerobic DNA
inhibitors |
|
Nitro- imidazole derivatives
|
Metronidazole# • Tinidazole • Ornidazole
|
|
|
Nitrofuran derivatives
|
Nitrofurantoin# • Furazolidone‡ • Nifurtoinol
|
|
|
| RNA synthesis |
|
Rifamycins/
RNA polymerase
|
Rifampicin • Rifabutin • Rifapentine • Rifaximin
|
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
|
gr+f/gr+a(t)/gr-p(c)/gr-o
|
|
|
|
|